rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Zydus Lifesciences Ltd.

532321 ZYDUSLIFE Group (A)

18 Oct,15:57
1021.65
0.75 (0.07%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Zydus Lifesciences Ltd.

BUYSELL
36,540 1,020.90 1,030.15 - 1,013.95 1,323.90 - 567.85 102,798.43
NSE | BSE

Zydus Lifesciences Ltd.

ZYDUSLIFE

18 Oct,15:59
1022.45
1.60 (0.16%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Zydus Lifesciences Ltd.

BUYSELL
1,368,450 1020.85 1,035.00 - 1,013.90 1,324.30 - 567.75 1,398,241,156.50

News for Zydus Lifesciences Ltd.

Zydus...
Zydus Lifesciences Gets USFDA Nod for Generic Schizophrenia Drug
Zydus Lifesciences has received USFDA approval to manufacture generic Paliperidone extended-release tablets, used to treat schizophrenia. The tablets will be produced at the company's Ahmedabad...
Oct 10, 2024 15:44
Zydus...
Zydus Lifesciences Gets USFDA Approval for Prostate Cancer Drug
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for the US market. The product will be manufactured at the company's...
Oct 02, 2024 16:22
Zydus Gets USFDA...
Zydus Gets USFDA Approval for Generic Prostate Cancer Drug
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad...
Sep 28, 2024 17:49
Zydus & CSIR-CDRI Develop Drug for CKD-Induced Osteoporosis
Zydus Lifesciences and CSIR-CDRI have partnered to develop a new drug for chronic kidney disease-induced osteoporosis, targeting Sclerostin inhibition. The collaboration aims to bring affordable...
Sep 27, 2024 12:20
Zydus...
Zydus Lifesciences Acquires Sterling Biotech's API Biz for Rs 84 cr
Zydus Lifesciences has acquired Sterling Biotech's API business, including a fermentation-based API production facility, for Rs 84 crore. The acquisition is expected to be completed by December 31,...
Sep 17, 2024 14:20

More News for Zydus Lifesciences Ltd. »

(Rs. Crore)

Financial Results of Zydus Lifesciences Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,818.708,731.607,981.907,790.406,347.40
Operating profit4,058.702,454.401,918.102,319.101,423.10
Interest390.70278.20134.9070.90233.90
Gross profit4,752.802,724.601,961.902,327.102,038.60
EPS (Rs)34.2115.118.3814.4213.80

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Zydus Lifesciences Ltd.

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020. Wikipedia

News for Pharmaceuticals and health care

NSDL Asset Value...
NSDL Asset Value Hits Rs 500 Lakh Crore
National Securities Depository (NSDL) reports assets held in dematerialized form reach Rs 500 lakh crore, marking a significant milestone in the Indian financial market.
Oct 18, 2024 22:23
Bullion Rates...
Bullion Rates Today: Gold & Silver Prices in India - Oct 18
Get the latest bullion rates for gold and silver in India. Check today's prices for standard gold, ornament gold, and silverspot. Updated on October 18th.
Oct 18, 2024 21:53
PE/VC Investments...
PE/VC Investments Drop 40% to $8.8 Billion in Q2: Report
Private equity and venture capital investments fell 40% to USD 8.8 billion in Q2 2023, driven by geopolitical uncertainty, says a report by IVCA and EY. Despite a rise in deal volume, cautious...
Oct 18, 2024 21:42
Kotak Mahindra...
Kotak Mahindra Bank Acquires StanC India's Personal Loan Book
Kotak Mahindra Bank to acquire Standard Chartered Bank's Rs 4,100 crore personal loan portfolio, marking a significant acquisition in the Indian banking sector.
Oct 18, 2024 20:29
Oberoi Realty Q2...
Oberoi Realty Q2 Profit Jumps 29% to Rs 589.44 Crore
Oberoi Realty's consolidated net profit surged 29% to Rs 589.44 crore in Q2 FY24, driven by strong revenue growth. Read more.
Oct 18, 2024 20:23

More News »

Top News

NSDL Asset Value...
NSDL Asset Value Hits Rs 500 Lakh Crore
National Securities Depository (NSDL) reports assets held in dematerialized form reach Rs 500 lakh crore, marking a significant milestone in the Indian financial market.
Oct 18, 2024 22:23
Bullion Rates...
Bullion Rates Today: Gold & Silver Prices in India - Oct 18
Get the latest bullion rates for gold and silver in India. Check today's prices for standard gold, ornament gold, and silverspot. Updated on October 18th.
Oct 18, 2024 21:53
PE/VC Investments...
PE/VC Investments Drop 40% to $8.8 Billion in Q2: Report
Private equity and venture capital investments fell 40% to USD 8.8 billion in Q2 2023, driven by geopolitical uncertainty, says a report by IVCA and EY. Despite a rise in deal volume, cautious...
Oct 18, 2024 21:42
L&T Finance Q2 Profit Up 17%, Challenges Ahead
L&T Finance reported a 17% rise in Q2 net profit to Rs 696 crore, but expects challenges in the next six months due to sectoral headwinds and a volatile macro environment.
Oct 18, 2024 21:29
India's Software Exports Hit USD 205.2 Billion in 2023-24: RBI
India's software services exports rose to USD 205.2 billion in 2023-24, with the US being the major destination, according to a Reserve Bank of India survey. Learn more about the growth and key...
Oct 18, 2024 20:54

More Top News »

Report Card

PE Ratios
29.84
EPS (Rs.)
34.21
Sales (Rs. Cr)
4,160.20
Face Value (Rs.)
1
Net Profit Margin (%)
31.81
Last Bonus
1:2
Last Dividend(%)
300
Return on Average Equity
21.89

BSE Announcements from Zydus Lifesciences Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Press Release / Media Release - 1 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Press Release / Media Release - 4 day(s) ago

Compare 'Zydus Lifesciences Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,897.95
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,709.60
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,068.55
  • Compare
  • Max Healthcare Institute Ltd.
  • 963.80
  • Compare
  • Divi's Laboratories Ltd.
  • 6,122.20
  • Compare
  • Alkem Laboratories Ltd.
  • 6,095.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,513.40
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 50 now and I want to retire at the age of 56...

I have purchased a residential flat in december 2021...

I purchased a house in 2010 at Rs 16 lakhs. I want...

Hello Sir, I plan to invest in the following funds...

My son age 25 yrs, earning 35000pm invested in...

I have taken early retirement due to my health...

More REDIFFGURUS

RediffGurus

Money question

Dear Mr.Vivek,Please inform how to reduce Income tax...

Zydus Lifesciences Ltd. performance snapshot

If you had invested Rs.  in Zydus Lifesciences Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Zydus Lifesciences Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Screener » Open Demat »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Zydus Lifesciences Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Zydus Lifesciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close